Voretigene Neparvovec in Retinal Diseases: A Review of the Current Clinical Evidence
Jie Gao,1 Rehan M Hussain,2 Christina Y Weng1 1Department of Ophthalmology, Baylor College of Medicine, Houston, TX, USA; 2Retina Associates, Elmhurst, IL, USACorrespondence: Christina Y WengBaylor College of Medicine, Alkek Eye Center, 1977 Butler Blvd, Houston, TX 77030, USAEmail christina.weng@bc...
Guardado en:
Autores principales: | Gao J, Hussain RM, Weng CY |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6274fcbff62d431f9b72397dcc8d7d15 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Assessing the Accuracy, Quality, and Readability of Patient Accessible Online Resources Regarding Ocular Gene Therapy and Voretigene Neparvovec
por: Davuluri S, et al.
Publicado: (2021) -
Prescreening whole exome sequencing results from patients with retinal degeneration for variants in genes associated with retinal degeneration
por: Bryant L, et al.
Publicado: (2017) -
Relative frequency of inherited retinal dystrophies in Brazil
por: Fabiana Louise Motta, et al.
Publicado: (2018) -
Descriptive Study of a Cohort of 488 Patients with Inherited Retinal Dystrophies
por: Coco-Martin RM, et al.
Publicado: (2021) -
Efficacy of valproic acid for retinitis pigmentosa patients: a pilot study
por: Iraha S, et al.
Publicado: (2016)